Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.
Weber O, Schlemmer KH, Hartmann E, Hagelschuer I, Paessens A, Graef E, Deres K, Goldmann S, Niewoehner U, Stoltefuss J, Haebich D, Ruebsamen-Waigmann H, Wohlfeil S.
Weber O, et al. Among authors: hartmann e.
Antiviral Res. 2002 May;54(2):69-78. doi: 10.1016/s0166-3542(01)00216-9.
Antiviral Res. 2002.
PMID: 12062392